相似文献
1
Microparticles and microRNAs of endothelial progenitor cells ameliorate acute kidney injury.
Kidney Int. 2012 Aug;82(4):375-7. doi: 10.1038/ki.2012.152.
2
Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells.
Kidney Int. 2012 Aug;82(4):412-27. doi: 10.1038/ki.2012.105. Epub 2012 Apr 11.
3
Epac-1 activator 8-O-cAMP augments renoprotective effects of syngeneic [corrected] murine EPCs in acute ischemic kidney injury.
Am J Physiol Renal Physiol. 2010 Jan;298(1):F78-85. doi: 10.1152/ajprenal.00485.2009. Epub 2009 Nov 11.
4
Intravenous Administration of Allogenic Cell-Derived Microvesicles of Healthy Origins Defend Against Atherosclerotic Cardiovascular Disease Development by a Direct Action on Endothelial Progenitor Cells.
Cells. 2020 Feb 12;9(2):423. doi: 10.3390/cells9020423.
5
Human Endothelial Progenitor Cells Protect the Kidney against Ischemia-Reperfusion Injury via the NLRP3 Inflammasome in Mice.
Int J Mol Sci. 2022 Jan 28;23(3):1546. doi: 10.3390/ijms23031546.
6
Human urine-derived stem cells protect against renal ischemia/reperfusion injury in a rat model via exosomal which targets .
Theranostics. 2020 Jul 25;10(21):9561-9578. doi: 10.7150/thno.42153. eCollection 2020.
7
Hematopoietic microRNA-126 protects against renal ischemia/reperfusion injury by promoting vascular integrity.
J Am Soc Nephrol. 2014 Aug;25(8):1710-22. doi: 10.1681/ASN.2013060640. Epub 2014 Mar 7.
8
Effects of transplanted circulating endothelial progenitor cells and platelet microparticles in atherosclerosis development.
Biol Cell. 2016 Aug;108(8):219-43. doi: 10.1111/boc.201500104. Epub 2016 Apr 24.
9
miR-486-5p protects against rat ischemic kidney injury and prevents the transition to chronic kidney disease and vascular dysfunction.
Clin Sci (Lond). 2024 May 22;138(10):599-614. doi: 10.1042/CS20231752.
10
Microparticles of healthy origins improve endothelial progenitor cell dysfunction via microRNA transfer in an atherosclerotic hamster model.
Acta Physiol (Oxf). 2017 Dec;221(4):230-249. doi: 10.1111/apha.12896. Epub 2017 Jun 8.
引用本文的文献
1
Emerging Frontiers in acute kidney injury: The role of extracellular vesicles.
Bioact Mater. 2025 Feb 18;48:149-170. doi: 10.1016/j.bioactmat.2025.02.018. eCollection 2025 Jun.
2
Circulating non-coding RNAs in chronic kidney disease and its complications.
Nat Rev Nephrol. 2023 Sep;19(9):573-586. doi: 10.1038/s41581-023-00725-w. Epub 2023 Jun 7.
3
CD34 positive cells as endothelial progenitor cells in biology and medicine.
Front Cell Dev Biol. 2023 Apr 17;11:1128134. doi: 10.3389/fcell.2023.1128134. eCollection 2023.
4
[Application of Extracellular Vesicles Derived from Vascular Endothelial/Endothelial Progenitor Cells in Tissue Regeneration and Repair].
Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 Mar;53(2):355-360. doi: 10.12182/20220360507.
5
Latest Advances in Endothelial Progenitor Cell-Derived Extracellular Vesicles Translation to the Clinic.
Front Cardiovasc Med. 2021 Oct 4;8:734562. doi: 10.3389/fcvm.2021.734562. eCollection 2021.
6
Endothelial Extracellular Vesicles: From Keepers of Health to Messengers of Disease.
Int J Mol Sci. 2021 Apr 28;22(9):4640. doi: 10.3390/ijms22094640.
7
Stem/progenitor cell in kidney: characteristics, homing, coordination, and maintenance.
Stem Cell Res Ther. 2021 Mar 20;12(1):197. doi: 10.1186/s13287-021-02266-0.
8
Mesenchymal stem cells and acellular products attenuate murine induced colitis.
Stem Cell Res Ther. 2020 Nov 30;11(1):515. doi: 10.1186/s13287-020-02025-7.
9
Putative endothelial progenitor cells do not promote vascular repair but attenuate pericyte-myofibroblast transition in UUO-induced renal fibrosis.
Stem Cell Res Ther. 2019 Mar 21;10(1):104. doi: 10.1186/s13287-019-1201-5.
10
Application potential of stem/progenitor cell-derived extracellular vesicles in renal diseases.
Stem Cell Res Ther. 2019 Jan 8;10(1):8. doi: 10.1186/s13287-018-1097-5.
本文引用的文献
1
Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells.
Kidney Int. 2012 Aug;82(4):412-27. doi: 10.1038/ki.2012.105. Epub 2012 Apr 11.
2
Role of microvesicles in acute kidney injury.
Contrib Nephrol. 2011;174:191-199. doi: 10.1159/000329397. Epub 2011 Sep 9.
3
Exosomes and the kidney: prospects for diagnosis and therapy of renal diseases.
Kidney Int. 2011 Dec;80(11):1138-45. doi: 10.1038/ki.2011.292. Epub 2011 Aug 31.
4
MicroRNA-mediated regulation of the angiogenic switch.
Curr Opin Hematol. 2011 May;18(3):171-6. doi: 10.1097/MOH.0b013e328345a180.
5
Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunction.
Antioxid Redox Signal. 2011 Aug 15;15(4):933-48. doi: 10.1089/ars.2010.3502. Epub 2010 Dec 13.
6
Exosomes/microvesicles as a mechanism of cell-to-cell communication.
Kidney Int. 2010 Nov;78(9):838-48. doi: 10.1038/ki.2010.278. Epub 2010 Aug 11.
7
RISC hitches onto endosome trafficking.
Nat Cell Biol. 2009 Sep;11(9):1049-51. doi: 10.1038/ncb0909-1049.
8
Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence.
J Cell Mol Med. 2009 Mar;13(3):454-71. doi: 10.1111/j.1582-4934.2008.00639.x.
9
Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126.
Development. 2008 Dec;135(24):3989-93. doi: 10.1242/dev.029736. Epub 2008 Nov 5.
Zotero 插件